Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Michael Goldberg
AddedMar 31, 2024
UpdatedMay 31, 2026
Michael Goldberg

Michael Goldberg

Board Member, CareDx

CrunchbaseLinkedIn

Michael Goldberg's Career

CareDx
CareDx

Brisbane, CA, US

Board Member· Board
Nodality
Nodality

South San Francisco, CA, US

Board Member· Board
Dnanexus
Dnanexus

Mountain View, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Michael Goldberg's Career

CareDx
CareDx
Public$574.9M7701999Brisbane, CA, US
Board Member· Board

Recent news

Calo raises $25 million to expand its ready-to-eat meal service beyond the Middle EastTechCrunch · 2024

Leadership at CareDx

Brook ByersBrook ByersBoard Member
Jay WohlgemuthJay WohlgemuthFounder
Ralph SnydermanRalph SnydermanBoard Member
Peter MaagPeter MaagBoard Member
Grace ColónGrace ColónBoard Member

Similar to CareDx

IncellDxIncellDxMenlo Park, CA, USMedical Instrumentsest. 2009IncellDxMenlo Park, CA, US · est. 2009

IncellDx, a California-based medical firm, develops and distributes diagnostic instruments for life-threatening diseases globally.

Series A · $9M26
TAI DiagnosticsTAI DiagnosticsWauwatosa, WI, USDiagnostic Testsest. 2013TAI DiagnosticsWauwatosa, WI, US · est. 2013

TAI Diagnostics: A Wisconsin-based biotech firm offering non-invasive, sensitive tests for transplant patients.

Series A · $29M11
SynapDxSynapDxLexington, MA, USDiagnostic Testsest. 2010SynapDxLexington, MA, US · est. 2010

SynapDX: Pioneering early autism detection through blood-based diagnostic tests.

Series B · $32.4M11
DxNADxNASt. George, UT, USDiagnostic TestsDxNASt. George, UT, US

DxNA LLC, a Utah-based medical organization, develops affordable, rapid molecular diagnostic tools, focusing on infectious diseases for underserved hospitals and clinics.

Angel · $6.6M19
Nodality
Nodality
Series B$62M752003South San Francisco, CA, US
Board Member· Board

Leadership at Nodality

Garry NolanGarry NolanBoard Member
Omar PerezOmar PerezFounder
Laura BregeLaura BregeCEO
Greg CritchfieldGreg CritchfieldBoard Member
David SingerDavid SingerBoard Member
Andrew R. AllenAndrew R. AllenBoard Member

Similar to Nodality

NormunityNormunityWest Haven, CT, USCancer Treatmentsest. 2021NormunityWest Haven, CT, US · est. 2021

Normunity: A biotech firm innovating precision immuno-oncology medicines to boost body's cancer immunity.

Series A · $65M15
Nuon TherapeuticsNuon TherapeuticsSan Mateo, CA, USTherapiesest. 2002Nuon TherapeuticsSan Mateo, CA, US · est. 2002

Nuon Therapeutics: A US-based biotech firm innovating therapies for autoimmune and inflammatory diseases.

Series A · $48M75
Dnanexus
Dnanexus
Series H$472.6M2922009Mountain View, CA, US
Board Member· Board

Leadership at Dnanexus

Jeffrey MargolisJeffrey MargolisBoard Member
Andreas SundquistAndreas SundquistCo-Founder
Krishna YeshwantKrishna YeshwantBoard Member
Thomas LaurThomas LaurCEO
Serafim BatzoglouSerafim BatzoglouCo-Founder
Arend SidowArend SidowCo-Founder

Michael Goldberg's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Michael Goldberg

Mike KoureyMike KoureyBoard Member · VarentecJack L. WyszomierskiJack L. WyszomierskiBoard Member · AthersysPaul CooleenPaul CooleenBoard Member · VizConnectDavid ZinsnerDavid ZinsnerBoard Member · CredoPaul AdlerPaul AdlerBoard Member · NBND CorpMichael PirainoMichael PirainoBoard Member · LabVoice